Bank Julius Baer & Co
HCA icon

Bank Julius Baer & Co’s HCA Healthcare HCA Stock Holding History

Bank Julius Baer & Co’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$152K Sell
390
-58
-13% -$24.5K ﹤0.01% 518
2026
Q1 		$212K Sell
448
-72
-14% -$36.2K ﹤0.01% 497
2025
Q4 		$243K Buy
520
+390
+300% +$181K ﹤0.01% 471
2025
Q3 		$55.5K Buy
130
+1
+0.8% +$388 ﹤0.01% 586
2025
Q2 		$49.6K Sell
129
-1
-0.8% -$360 ﹤0.01% 547
2025
Q1 		$44.9K Buy
130
+12
+10% +$3.86K ﹤0.01% 550
2024
Q4 		$39K Sell
118
-8,009
-99% -$2.8M ﹤0.01% 576
2024
Q3 		$3.92M Sell
8,127
-1,045
-11% -$383K 0.01% 238
2024
Q2 		$3.28M Buy
+9,172
New +$2.98M 0.01% 197
2022
Q4 		– Sell
-236
Closed -$43K – 587
2022
Q3 		$43K Buy
236
+150
+174% +$29.9K ﹤0.01% 508
2022
Q2 		$14K Buy
+86
New +$18.5K ﹤0.01% 572
2020
Q3 		– Sell
-20
Closed -$2K – 753
2020
Q2 		$2K Buy
+20
New +$2.08K ﹤0.01% 655

Other funds holding HCA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank Julius Baer & Co's HCA Position: Q2 2026 in Review

Bank Julius Baer & Co reduced its HCA Healthcare (HCA) stake by 13% in Q2 2026, selling an estimated $24.5K and leaving 390 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #518.

Bank Julius Baer & Co first reported a position in HCA in Q2 2020 and has held it in 12 quarters since. The position peaked at $3.92M in Q3 2024. 1,342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Bank Julius Baer & Co held 390 shares of HCA Healthcare worth $152K as of Q2 2026.
  • Bank Julius Baer & Co sold 58 HCA Healthcare shares in Q2 2026, an estimated $24.5K.
  • HCA Healthcare made up ﹤0.01% of Bank Julius Baer & Co's portfolio in Q2 2026, its #518 holding.
  • Bank Julius Baer & Co first reported a position in HCA Healthcare in Q2 2020 and has held it in 12 quarters since.
  • Bank Julius Baer & Co's HCA Healthcare position peaked at $3.92M in Q3 2024.
  • 1,342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.